LACOMIDE 50 MG

Država: Izrael

Jezik: engleski

Izvor: Ministry of Health

Aktivni sastojci:

LACOSAMIDE

Dostupno od:

CTS CHEMICAL INDUSTRIES LTD, ISRAEL

ATC koda:

N03AX18

Farmaceutski oblik:

FILM COATED TABLETS

Sastav:

LACOSAMIDE 50 MG

Administracija rute:

PER OS

Tip recepta:

Required

Proizveden od:

CTS CHEMICAL INDUSTRIES LTD, ISRAEL

Područje terapije:

LACOSAMIDE

Terapijske indikacije:

Lacomide is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.

Datum autorizacije:

2023-01-29

Uputa o lijeku

PATIENT LEAFLET IN ACCORDANCE
WITH THE PHARMACISTS’ REGULATIONS
(PREPARATIONS) – 1986
The medicine is dispensed with a doctor’s
prescription only
LACOMIDE 50 MG
film-coated tablets
LACOMIDE 100 MG
film-coated tablets
LACOMIDE 150 MG
film-coated tablets
LACOMIDE 200 MG
film-coated tablets
Each Lacomide film-coated tablet contains
lacosamide 50 mg, 100 mg, 150 mg or 200 mg.
For information regarding inactive ingredients see
section 6 “Additional information”.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING
THE MEDICINE. This leaflet contains concise
information about the medicine. If you have
any other questions, refer to the doctor or the
pharmacist.
This medicine has been prescribed for treatment
of your illness. Do not pass it on to others. It
may harm them even if it seems to you that their
medical condition is similar.
Epilepsy is an illness characterized by recurring
convulsion seizures. The medicine Lacomide is
given when the state of epilepsy is such that the
seizures are initially partial (involving only one side
of the brain), but may develop into generalized
seizures (that involve extensive areas on both
sides of the brain).
Treatment with Lacomide is long-term. Do not stop
the treatment without an explicit instruction from
the doctor. Stopping the treatment may cause a
recurrence or worsening of the disease symptoms.
See section 3 in the subsection “IF YOU STOP
TAKING THE MEDICINE”.
1. WHAT IS THE MEDICINE INTENDED FOR?
• Lacomide is intended for use in adults,
adolescents and children aged 4 years and older.
• Lacomide is indicated for the treatment of a
certain type of epilepsy characterized by the
occurrence of “partial-onset seizure with or
without secondary generalization).
• Lacomide can be used alone or in combination
with additional antiepileptic medicines.
Lacomide contains lacosamide, which belongs
to the group of substances called “antiepileptic
medicines”. These medicines are used for
treatment of epilepsy.
THERAPEUTIC CLASS: anticonvulsant.
2. BEFORE USING THE MEDIC